Lvw Advisors, LLC Pfizer Inc Transaction History

Lvw Advisors, LLC

$771 Million
Q3 2024

A detailed history of Lvw Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Lvw Advisors, LLC holds 9,906 shares of PFE stock, worth $263,697. This represents 0.04% of its overall portfolio holdings.

Number of Shares

9,906

Previous 20,338 51.29%

Holding current value

$263,697

Previous $569,000 49.74%

% of portfolio

0.04%

Previous 0.08%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$27.7 - $31.39 $288,966 - $327,460	-10,432 Reduced 51.29%	9,906 $286,000
Q2 2024 Jul 15, 2024	SELL	$25.26 - $29.6 $232,543 - $272,497	-9,206 Reduced 31.16%	20,338 $569,000
Q1 2024 Apr 17, 2024	SELL	$25.89 - $29.73 $194,019 - $222,796	-7,494 Reduced 20.23%	29,544 $819,000
Q4 2023 Jan 12, 2024	SELL	$26.13 - $33.94 $656,855 - $853,183	-25,138 Reduced 40.43%	37,038 $1.07 Million
Q3 2023 Oct 10, 2023	SELL	$32.09 - $37.51 $510,744 - $597,009	-15,916 Reduced 20.38%	62,176 $2.06 Million
Q2 2023 Jul 14, 2023	SELL	$36.12 - $41.79 $331,328 - $383,339	-9,173 Reduced 10.51%	78,092 $2.86 Million
Q1 2023 May 02, 2023	SELL	$39.39 - $51.28 $117,579 - $153,070	-2,985 Reduced 3.31%	87,265 $3.56 Million
Q4 2022 Jan 18, 2023	SELL	$41.75 - $54.5 $69,722 - $91,015	-1,670 Reduced 1.82%	90,250 $0
Q3 2022 Oct 13, 2022	BUY	$43.76 - $53.42 $17,985 - $21,955	411 Added 0.45%	91,920 $4.02 Million
Q2 2022 Jul 22, 2022	SELL	$46.53 - $55.17 $280,110 - $332,123	-6,020 Reduced 6.17%	91,509 $4.8 Million
Q1 2022 May 02, 2022	SELL	$45.75 - $56.69 $176,091 - $218,199	-3,849 Reduced 3.8%	97,529 $5.05 Million
Q4 2021 Jan 26, 2022	SELL	$41.32 - $61.25 $312,751 - $463,601	-7,569 Reduced 6.95%	101,378 $5.99 Million
Q3 2021 Nov 02, 2021	SELL	$39.25 - $50.42 $101,422 - $130,285	-2,584 Reduced 2.32%	108,947 $4.69 Million
Q2 2021 Jul 15, 2021	BUY	$35.91 - $40.68 $81,012 - $91,774	2,256 Added 2.06%	111,531 $4.37 Million
Q1 2021 Apr 19, 2021	SELL	$33.49 - $37.77 $120,262 - $135,632	-3,591 Reduced 3.18%	109,275 $3.96 Million
Q4 2020 Feb 04, 2021	BUY	$33.47 - $42.56 $133,411 - $169,644	3,986 Added 3.66%	112,866 $4.16 Million
Q3 2020 Oct 29, 2020	BUY	$31.75 - $37.25 $35,369 - $41,496	1,114 Added 1.03%	108,880 $4 Million
Q2 2020 Aug 11, 2020	BUY	$30.12 - $36.54 $121,835 - $147,804	4,045 Added 3.9%	107,766 $3.52 Million
Q1 2020 Apr 23, 2020	BUY	$27.03 - $38.62 $565,305 - $807,698	20,914 Added 25.26%	103,721 $3.39 Million
Q4 2019 Feb 10, 2020	BUY	$32.92 - $37.36 $118,479 - $134,458	3,599 Added 4.54%	82,807 $3.24 Million
Q3 2019 Oct 22, 2019	BUY	$32.49 - $42.13 $79,568 - $103,176	2,449 Added 3.19%	79,208 $2.85 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $249,984 - $280,675	-6,760 Reduced 8.09%	76,759 $3.33 Million
Q1 2019 May 03, 2019	BUY	$37.5 - $41.2 $54,150 - $59,492	1,444 Added 1.76%	83,519 $3.55 Million
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $838,799 - $956,323	-21,804 Reduced 20.99%	82,075 $3.58 Million
Q3 2018 Nov 02, 2018	SELL	$34.47 - $41.81 $37,744 - $45,781	-1,095 Reduced 1.04%	103,879 $4.58 Million
Q2 2018 Jul 31, 2018	BUY	$32.98 - $35.16 $58,011 - $61,846	1,759 Added 1.7%	104,974 $3.81 Million
Q1 2018 Apr 20, 2018	SELL	$31.91 - $37.02 $53,321 - $61,860	-1,671 Reduced 1.59%	103,215 $3.66 Million
Q4 2017 Feb 12, 2018	BUY	$33.26 - $35.29 $358,742 - $380,637	10,786 Added 11.46%	104,886 $3.8 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $561,441 - $618,490	18,111 Added 23.83%	94,100 $3.36 Million
Q2 2017 Aug 10, 2017	BUY	N/A	75,989	75,989 $2.55 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lvw Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lvw Advisors, LLC with notifications on news.

Account